Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trials CANCER Fakhry, C., Zhang, Q., Gillison, M. L., Nguyen-Tan, P., Rosenthal, D. I., Weber, R. S., Lambert, L., Trotti, A. M., Barrett, W. L., Thorstad, W. L., Yom, S. S., Wong, S. J., Ridge, J. A., Rao, S. D., Spencer, S., Fortin, A., Raben, D., Harris, J., Quynh-Thu Le 2019; 125 (12): 2027–38
View details for DOI 10.1002/cncr.32025
View details for Web of Science ID 000470925600013